12:00 AM
Oct 12, 2015
 |  BC Week In Review  |  Company News  |  Deals

Amdipharm Mercury, Concordia Healthcare deal

Concordia will acquire fellow generic and pharmaceutical company Amdipharm from private equity firm Cinven for up to $3.6 billion, including debt. The acquisition consists of L800 million ($1.2 billion) in cash and 8.5 million of Concordia shares valued at C$939...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >